German firm DFE Pharma has launched its new Centre of Excellence (CoE) 'Closer to the Formulator' (C2F) in Hyderabad. The C2F centre is based in Genome Valley, a hub of major Indian and global biopharmaceutical companies and renowned research organisations. C2F helps pharma companies to shorten the time from a concept to a finished commercial product through expertise in all phases of pharma development.
The services offered by this new state-of-the-art facility are mainly focused on oral solid dosage forms, comprising all types of pre-registration work including development, scale-up, and technology transfer. Formulation support includes specialised dosage forms such as orally disintegrating, effervescent, chewable, and sublingual tablets, minitablets, etc. C2F capabilities also support efficiency projects such as conversion from wet granulation to direct compression.
The centre works with active pharmaceutical ingredients (APIs) and can utilise innovative concepts with model APIs. The equipment covers an instrumented tablet press, an automated capsule filling machine, a tablet coater, a blister packaging machine, stability chambers, and state-of-the-art analytical equipment. The C2F offering can provide pharmaceutical companies with multiple advantages such as significantly lowering the number of development cycles, for example, and reducing formulation costs when launching a medicine.
